MedPath

Carnoy's Solution Versus Formalin in Rectal and Gastric Cancer Specimens Following: a Randomized Trial

Not Applicable
Completed
Conditions
Gastric Adenocarcinoma
Rectal Cancer
Interventions
Other: 10% neutral buffered formaldehyde
Other: Carnoy's solution
Registration Number
NCT02629315
Lead Sponsor
Instituto do Cancer do Estado de São Paulo
Brief Summary

This study evaluates the number of lymph nodes dissected in specimens following fixation with 10% neutral buffered formaldehyde or Carnoy's solution. Specimens were randomized for fixation in each solution.

Detailed Description

Carnoy's solution is a tissue fixative that has alcohol allowing for fat clearing along with tissue fixation. Specimens were randomized after the surgical procedure. The perivisceral fat was removed from the stomach and the lymph node stations disected and then fixed in formalin or carnoy's solution for 24-48h. After dissection the residual fat from the formalin group was re-fixed in carnoy and re-disected.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
130
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
10% neutral buffered formaldehyde10% neutral buffered formaldehydeSpecimens will be fixed for 24-48hours in 10% neutral buffered formaldehyde and then dissected for lymph nodes.
Carnoy's solutionCarnoy's solutionSpecimens will be fixed for 24-48hours in Carno'ys solution and then dissected for lymph nodes.
Primary Outcome Measures
NameTimeMethod
Lymph node yield10 days - accessed with the pathological report for each specimen

Primary outcome will be the total number of lymph nodes dissected in each specimen

Secondary Outcome Measures
NameTimeMethod
Dissection duration10 days - accessed with the pathological report for each specimen

Secondary outcome will be measured in minutes, counting from the start to the end of the dissection

© Copyright 2025. All Rights Reserved by MedPath